Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:25 PM
Ignite Modification Date:
2025-12-24 @ 7:25 PM
NCT ID:
NCT02864303
Eligibility Criteria:
Inclusion Criteria:
* Men/Women;
* Aged ≥ 55 years and 80 years;
* Patients mild cognitive impairment (MCI), not answering either the criteria of a normal cognitive functioning or the criteria of the insanity, but meeting the criteria of diagnosis of following MCI in the term of a complete cognitive balance sheet (assessment) and according to the diagnostic procedure published by the work group on the MCI of the EADC:
* Mnesic complaint
* Decline of the cognitive performances with regard to the previous capacities
* Cognitive disorders(confusions) objectified by the clinical evaluation (change of the memory and/or another cognitive sphere)
* The cognitive change has no echo on the everyday life
* Not dementia syndrome
* Signature of the informed consent by the patient;
* Subject affiliated to a national insurance scheme.
Exclusion Criteria:
* Edentulous total or poor oral hygiene;
* Absence of the signed informed consent;
* Clinical and laboratory information insufficient or unavailable;
* Patient deprived of freedom, by court or administrative order;
* Major protected by law;
* Presence of a contagious viral affection (HIV, hepatitis B and C);
* Patient included in a therapeutic trial targeting the metabolism of metabolism of amyloid peptides ;
* Patient in period of relative exclusion with regard to another protocol or for which the annual maximum amount of the 4500-compensations was reached.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
55 Years
Maximum Age:
80 Years
Study:
NCT02864303
Study Brief:
Protocol Section:
NCT02864303